188 related articles for article (PubMed ID: 12397619)
1. NO-donors (VII [1]): synthesis and cyclooxygenase inhibitory properties of N-and S-nitrooxypivaloyl-cysteine derivatives of naproxen -- a novel type of NO-NSAID.
Kartasasmita RE; Laufer S; Lehmann J
Arch Pharm (Weinheim); 2002 Aug; 335(8):363-6. PubMed ID: 12397619
[TBL] [Abstract][Full Text] [Related]
2. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
3. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
4. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.
Huang Z; Velázquez CA; Abdellatif KR; Chowdhury MA; Reisz JA; DuMond JF; King SB; Knaus EE
J Med Chem; 2011 Mar; 54(5):1356-64. PubMed ID: 21280601
[TBL] [Abstract][Full Text] [Related]
5. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE
Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994
[TBL] [Abstract][Full Text] [Related]
6. NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Zacharowski P; Breese E; Wood E; Del Soldato P; Warner T; Mitchell J
Eur J Pharmacol; 2005 Jan; 508(1-3):7-13. PubMed ID: 15680249
[TBL] [Abstract][Full Text] [Related]
7. Diazen-1-ium-1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Chen QH; Knaus EE
Bioorg Med Chem; 2008 Mar; 16(6):3302-8. PubMed ID: 18096394
[TBL] [Abstract][Full Text] [Related]
8. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2009 Jun; 19(11):3014-8. PubMed ID: 19419861
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
10. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE
Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cyclooxygenase inhibitory properties of novel (+) 2-(6-methoxy-2-naphthyl)propanoic acid (naproxene) derivatives.
Abadi AH; Laufer S; Lehmann J
Arch Pharm (Weinheim); 2001 Mar; 334(3):104-6. PubMed ID: 11315336
[TBL] [Abstract][Full Text] [Related]
12. COX-2 selective NSAID decreases bone ingrowth in vivo.
Goodman S; Ma T; Trindade M; Ikenoue T; Matsuura I; Wong N; Fox N; Genovese M; Regula D; Smith RL
J Orthop Res; 2002 Nov; 20(6):1164-9. PubMed ID: 12472224
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide release is not required to decrease the ulcerogenic profile of nonsteroidal anti-inflammatory drugs.
Jain S; Tran S; El Gendy MA; Kashfi K; Jurasz P; Velázquez-Martínez CA
J Med Chem; 2012 Jan; 55(2):688-96. PubMed ID: 22148253
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-inflammatory activity of a series of N-substituted naproxen glycolamides: nitric oxide-donor naproxen prodrugs.
Ranatunge RR; Augustyniak ME; Dhawan V; Ellis JL; Garvey DS; Janero DR; Letts LG; Richardson SK; Shumway MJ; Trocha AM; Young DV; Zemtseva IS
Bioorg Med Chem; 2006 Apr; 14(8):2589-99. PubMed ID: 16356728
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib analogs possessing a N-(4-nitrooxybutyl)piperidin-4-yl or N-(4-nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies.
Chowdhury MA; Abdellatif KR; Dong Y; Yu G; Huang Z; Rahman M; Das D; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2010 Feb; 20(4):1324-9. PubMed ID: 20097072
[TBL] [Abstract][Full Text] [Related]
17. Novel (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic ester prodrugs possessing a diazen-1-ium-1,2-diolate moiety: design, synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
Abdellatif KR; Dong Y; Chen QH; Chowdhury MA; Knaus EE
Bioorg Med Chem; 2007 Nov; 15(21):6796-801. PubMed ID: 17764958
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
Ranatunge RR; Augustyniak M; Bandarage UK; Earl RA; Ellis JL; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schroeder JD; Shumway MJ; Tam SW; Trocha AM; Young DV
J Med Chem; 2004 Apr; 47(9):2180-93. PubMed ID: 15084117
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the cyclooxygenase inhibitor-NO donors (CINOD), NMI-1182 and AZD3582, using in vitro biochemical and pharmacological methods.
Young DV; Cochran ED; Dhawan V; Earl RA; Ellis JL; Garvey DS; Janero DR; Khanapure SP; Letts LG; Melim TL; Murty MG; Shumway MJ; Wey SJ; Zemtseva IS; Selig WM
Biochem Pharmacol; 2005 Nov; 70(9):1343-51. PubMed ID: 16168964
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives.
Dao TT; Chi YS; Kim J; Kim HP; Kim S; Park H
Bioorg Med Chem Lett; 2004 Mar; 14(5):1165-7. PubMed ID: 14980657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
